Analysis Commentary: journals must facilitate the dissemination and scrutiny of clinical research BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5397 (Published 12 October 2010) Cite this as: BMJ 2010;341:c5397 Article Related content Metrics Responses Peer review Related articles Analysis Data availability for industry sponsored trials: what should medical journals require? Published: 12 October 2010; BMJ 341 doi:10.1136/bmj.c5391 Editorial Missing clinical trial data: setting the record straight Published: 12 October 2010; BMJ 341 doi:10.1136/bmj.c5641 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362 Cited by... Missing clinical trial data: setting the record straightFulltext
